Heritable Human Genome Editing

Critical Social Justice Principles Published

(Berlin, June 17, 2024) An international coalition of scientists, civil society representatives, and scholars has issued a set of forward-looking principles about the debate on heritable human genome editing. The focus is on social justice.

Member organisations of the coalition

Member organisations of the coalition

The Gender Justice and Disability Rights Coalition on Heritable Genome Editing addresses—for the first time—the immense risks of heritable interventions in the human germline - that is, the modification of the DNA of embryos or germ cells in order to create so-called designer babies. It also examines the technology from a feminist and anti-eugenic perspective.

Link to full doc (PDF)
Link to summary (PDF)

Five years ago, a scientist "created" the first CRISPR babies. Although his dangerous experiment was condemned worldwide, a small circle of leading scientists continues to push for heritable genome editing research and testing in clinical trials - including in Germany. It is therefore important to decide now whether further development of this technology will benefit humanity or harm it.

Many high-ranking institutions have already published policy papers and recommendations. However, these usually focus on technical safety, while the major risk to society—such as increased discrimination against people with disabilities and other minority groups—is neglected. The unequal distribution of risk from clinical trials, which women and pregnant people in particular would bear, as well as the children created in this way and their offspring, is also rarely addressed.

In the new paper, the 16 authors from science, civil society, and academia define the prerequisites for a just and inclusive society. "On this basis, we come to the conclusion that germline interventions cannot be reconciled with feminist, anti-eugenic and human rights principles," summarizes Dr. Isabelle Bartram from the Gen-ethisches Netzwerk (Gen-ethical network) in Berlin, an organizational member of the international coalition.

More than 70 individuals and organizations from science, civil society and scholarly institutions support the principles. It is available in German, English and Spanish and provides important impetus for the socio-political debate about genome editing in humans. "In Germany, hereditary interventions in the human germline are still prohibited by the Embryo Protection Act, but we can already see from reproductive tourism that international regulation of controversial technologies such as egg “donation” and surrogacy is necessary to prevent unethical practices in countries with loose regulations," says Bartram.

"We want political decision-makers and the public to know that hereditary genome editing is not a niche issue, but that a lot is at stake for society," says Bartram. Taking the social impacts into account is just as important as the discussion about safety or ethics.

20. Juni 2024

Gen-ethisches Netzwerk e.V.

zur Artikelübersicht

Contact:

Dr. Isabelle Bartram
Tel. 0049 30-685 7073
Isabelle.bartram@gen-ethisches-netzwerk.de

More information on the topic:

Dossier: Human Genome Editing
International Debates on Germline Editing

The CRISPR-Cas "genetic scissors" enables genetic changes to be made faster than ever before. While the first patients are being treated with CRISPR therapies, germline interventions are still the subject of international debate. Their application carries a high technological and social risk.
 

Cover Dossier HHGE

Cover illustration: © JUN CEN (www.instagram.com/juncenart)

Nur durch Spenden ermöglicht!

Einige Artikel unserer Zeitschrift sowie unsere Online-Artikel sind sofort für alle kostenlos lesbar. Die intensive Recherche, das Schreiben eigener Artikel und das Redigieren der Artikel externer Autor*innen nehmen viel Zeit in Anspruch. Bitte tragen Sie durch Ihre Spende dazu bei, dass wir unsere vielen digitalen Leser*innen auch in Zukunft aktuell und kritisch über wichtige Entwicklungen im Bereich Biotechnologie informieren können.

Ja, ich spende!  Nein, diesmal nicht